Egalet Corporation (EGLT) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $1.00, down from yesterday’s close by -0.99%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Egalet Corporation (EGLT) currently trades with a market capitalization of $43.50 Million. That value represents a market adjusting for revenues that have been growing by 41.18 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$69.21 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.39 on a per share basis this quarter. Perhaps, that suggests something about why 1.27% of the outstanding share supply is held by institutional investors.
As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Egalet Corporation recorded a 52-week high of $10.00. It is now trading 9% off that level. The stock is trading $1.05 its 50-day moving average by 0.05%. The stock carved out a 52-week low down at $0.80.
In recent action, Egalet Corporation (EGLT) has made a move of -24.24% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 19.12% with $42.62 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of EGLT.